One sentence summary By tracking vaccine-driven Salmonella evolution in the intestine, it is possible to rationally design oligovalent oral vaccines that generate an evolutionary trap.
evolutionary trap. IgA targeting all fitness-neutral O-antigen escape variants of Salmonella Typhimurium rapidly selected for mutants with very short O-antigen: a phenotype known to display major fitness costs and virulence attenuation in naive hosts. Evolutionary trap vaccination therefore represents an alternative concept in vaccine design. This approach capitalizes on the inevitable and rapid evolution of bacteria in the gut, and can combine protection of the individual with elimination of virulent enteropathogen reservoirs.
4
This operon encodes the machinery to add glucose via an α-(1→4) linkage to the backbone 48 galactose (22) . It should be noted both O-acetylation and backbone-glucosylation represent 49 major changes in the hydrophobicity or steric properties of the O-antigen repeat unit, which 50
when extensively polymerized into full-length O-antigen will have major consequences for 51 antibody binding (24) (25) (26) . 52 53 We applied multiple techniques to determine the O-antigen structure of evolved S.Tm clones. 54 Flow cytometry with serotyping antibodies (Fig. 1F) , High Resolution-Magic Angle Spinning 55
(HR-MAS) on intact bacteria ( Fig. S2A and B) and 1 H-NMR (27) on purified 56 lipopolysaccharide ( Fig. S2C) confirmed the loss of abequose O-acetylation (O:5 to O:4) and 57 gain of α-(1→4)-linked glucosylation of galactose (O:12 to O:12-2) in clones from vaccinated 58 but diseased mice. The emergence of these variants was also observed at later stages during 59 chronic mouse infections with attenuated S.Tm (Fig. S3) . This was dependent on the presence 60 of Rag1 and IgA (Fig. S3 ), suggesting that IgA-dependent selective pressure for O-antigen 61
switching can be generated both by vaccination and by immunity arising naturally during 62
infection. 63 64 We then explored the underlying genetic mechanisms responsible for altered O-antigen 65 structure in the evolved clones. We first determined the stability of the observed O-antigen 66 phenotypes, i.e. whether we would see reversion during cultivation. In vitro serial passages of 67 evolved clones over 5 days revealed that the switch from O:5 to O:4 was a stable, uniform 68 phenotype ( Fig. 1F and S4A) . Sequencing of O:5-negative evolved clones revealed a 69 common 7 base-pair contraction of a tandem repeat within the oafA open reading frame, 70
generating a frame-shift and loss of function ( Fig. 2A and B) . Targeted deletion of oafA 71 (S.Tm ΔoafA ) generated an identical phenotype to the 7 bp deletion (Fig. 2B) . The same 72 mutation was detected in deposited genomes of S. Tm isolates from swine (28) and is found in 73
other O:5-negative serovars (e.g., Salmonella enterica Heidelberg CP031359.1 "Strain 5" 74 ( Fig. S5A)(29) ). As there are only two copies of the 7 base-pair motif in the wild type ORF, 75
the deletion of one 7 base-pair stretch is unlikely to be reversed(30) ( Fig. 2A, Fig. S5A ). 76 Intriguingly, deposited sequences also indicate copy number variation in a 9bp repeat in the 77 promoter region of oafA ( Fig. S5B) , suggesting a second possible site of microsatellite 78 instability in this gene. 79 80
When next assessed the stability of O:12 to O:12-2 switching, and its underlying genetic 81 mechanism. In contrast to O:5, the loss of O:12 was reversible during 3 rounds of serial 82 passage and both wild-type and evolved clones generated a bimodal staining pattern, 83 consistent with phase variation (Fig. 1F and S4A and B, Supplementary movies A and B , 84 clones referred to henceforth as O:12 Bimodal ). In line with known epigenetic regulation of the 85 gtrABC operon expression (22) , re-sequencing of the O:12 Bimodal strains revealed no consistent 86 mutational pattern (supplementary table 3 ). Instead, a semi-quantitative full-genome 87 methylation analysis supported that evolved O:12 Bimodal S.Tm clones form mixed populations 88 based on DNA methylation. Populations of evolved clones presented a high proportion of 89 chromosomes with a methylation pattern typical of the promoter of gtrABC in the ON 90 state (22, 31, 32) and a minor population in the OFF state ( Fig. 2C) : a situation which is 91 reversed in the ancestral strain. Targeted deletion of gtrC (S.Tm ΔgtrC ), the serotype-specific 92 glucosyl transferase of the gtrABC operon, abolished the ability of S.Tm to switch to an O: bimodal phenotype, even under strong in vivo selection (Fig. S6) . Mathematical modeling of 94 O:12/O:12-2 population sizes for fixed switching rates (supplementary methods, Fig. S4C-E) , 95 and comparison of flow cytometry and a lacZ transcriptional fusion, suggests that in vivo 96 selection of O:12-2-producing clones by IgA is sufficient to explain their relative proportion 97 in the O:12 Bimodal population without needing to infer any change in the switching rate ( Fig.  98  S4) . 99 100
Therefore S.Tm clones with an altered O-antigen structure rapidly emerged in vaccinated 101 mice. In order to quantify how strongly vaccine-induced IgA can select for O-antigen 102 variants, we designed competition experiments using isogenic mutant pairs carrying targeted 103 deletions in oafA and/or gtrC. This allowed us to study each O-antigen variant in isolation. 104 105 We first quantified selection for the genetic switch from an O: 5 poorly bound by IgA ( Fig. 3E) . Correspondingly, O:12-phase variation, vaccine escape and 129 inflammation were largely observed in mice where IgA bound poorly to the O:12-2 variant 130 (Fig 3F and G) . The mechanistic basis of this selective advantage could be confirmed by 131
complementation of the gtrC gene in trans ( Fig. S7) . It is interesting to note that gtrABC 132 operons are often found in temperate phage (20, 23) , suggesting that the ability of S.Tm to 133
quickly evade IgA mediated immunity may be further promoted by co-option of phage-134 encoded fitness factors (morons(33)).
136
Therefore IgA escapers, i.e. S.Tm mutants or phase variants only weakly recognized by 137 vaccine-induced IgA, arise within 1-3 days of infection. Wherever IgA escapers dominated 138
we observed full invasive and inflammatory disease ( Fig. S8) . Thus, both mutation and 139 epigenetic switching processes shape the O-antigen structure of Salmonella and can increase 140 the pathogen's fitness in the intestine of mice immune to specific serotypes. These changes 141
can occur without any major loss of pathogen fitness in naive hosts ( Fig. 3A and D broader antibody response ( Fig. 4A) , we observed equally good protection in both vaccinated 149 groups (Fig. S9) . However, closer observation revealed that PA-S.Tm ET vaccination selected 150
for another class of O-antigen variant: mutations generating a single-repeat O-antigen (34) . 151
These can be identified by weak binding to typing antisera ( Fig. 4B ) and by gel 152 electrophoresis of purified LPS (Fig.4C ). Sequencing of evolved clones revealed a large 153 deletion encompassing the wzyB gene, encoding the O-antigen polymerase(34) ( Fig. 4E, Fig.  154 S10 also found in some "non-typable" S.Tm isolates from human (34) from PA-S.Tm ΔoafA vaccinated mice showed higher titres against the long O-antigen than the 160 single-repeat O-antigen ( Fig. 4D ). This weaker binding to the very short O-antigen is 161 consistent with lower O-antigen abundance or loss of avidity ( Fig. 4B, Fig. S1 ).
163
Single infections revealed that, in comparison to isogenic wild type counterparts, wzyB-164 deficient mutants (synthetic or evolved) are significantly less efficient at colonizing the gut of 165 streptomycin pretreated naïve mice (Fig. 4F ), disseminating systemically ( Fig. 4G ) and 166 triggering inflammation ( Fig. 4H) . This attenuation can be attributed to compromised outer 167 membrane integrity(36) (Fig S11) .
169
We then tested whether IgA-mediated selection could drive outgrowth of clean wzyB deletion mock-vaccinated or antibody-deficient mice revealed a large fitness cost of the wzyB deletion 173 in naive animals, as observed in earlier studies(34, 37) ( Fig. 4I) . However, in the gut of 174 vaccinated mice, the fitness cost of decreased outer-membrane integrity in wzyB mutants was 175 clearly outweighed by the benefit of avoiding O-antigen specific IgA binding ( Fig. 4I) .
176
Vaccinated IgA -/mice were indistinguishable from naive mice in these experiments, i.e. IgA 177
and not any other effect of the vaccine was responsible for the phenotype. PA-S.Tm ET -elicited 178
IgA can therefore select for mutants with a fitness cost in naïve hosts.
180
To demonstrate that vaccine-induced IgA, and not further genetic change in S.Tm drive this 181 out-competition, we carried out fecal transfer experiments. Full fecal pellets from PA-S.Tm ET 182 vaccinated mice that had been infected for 4 days with the short/long O-antigen mixture were 183 delivered to streptomycin-treated naïve hosts. S.Tm ΔoafA ΔgtrC ΔwzyB (single-repeat O-antigen) 184 dominated the population in the donor feces. However, on transfer to the naive environment 185
the wzyB mutant was rapidly out-competed by the S.Tm ΔoafA ΔgtrC (full length O-antigen) ( Fig.  186 4J-L). Thus, outgrowth in vaccinated mice is not due to compensatory mutations in the wzyB 187 mutants, but to antibody-mediated selection. In real transmission settings, for example 188 between farm animals where the intestinal niche is limited and transmission includes a period 189 of exposure to environmental stresses, we expect these mutants to transmit very poorly. 190
191
In conclusion IgA induced by "Evolutionary Trap" vaccines can drive the outgrowth of S.Tm 192 mutants producing very short O-antigens. Such mutants have a major fitness disadvantage on 193 transmission into naive hosts, with important implications for disease spread. While the 194 cocktail of O-antigen variants incorporated into evolutionary trap vaccines will be strain-195 specific, the relative ease of production and low costs of inactivated whole-cell oral vaccines 196
suggest that this could be feasible either for pandemic strain targeting, personalized medicine 197 or farm-specific vaccines. 198 199
Intestinal bacteria, which typically form large populations that evolve rapidly, have proven 200
highly challenging to target with standard vaccine design: i.e. vaccines targeting a single 201 conserved antigen. Here we suggest an alternative strategy, which turns the rapid evolution of 202 gut bacteria from a major challenge into an advantage. Using oligovalent vaccines, we can 203 generate a breadth of IgA responses against all fitness-neutral O-antigen modifications. These 204 force the emergence of S.Tm variants with a fitness disadvantage in naïve hosts. The 205 "Evolutionary trap" approach therefore has considerable potential as prophylaxis for diseases 206 caused by common, increasingly antibiotic resistant, Enterobacteriaceae in both humans and 207 farm animals. 208 acknowledges Delphine Cornillet for serum resistance measurements.
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• Supplementary Table S1- Normalized read counts and were bred in individually ventilated cages or flexible-film isolators at this facility. 16
Vaccinations were started between 5 and 6 weeks of age, and males and females were 17
randomized between groups to obtain identical ratios wherever possible. As strong 18
phenotypes were expected, we adhered to standard practice of analysing at least 5 mice per 19
group. Researchers were not blinded to group allocation. 20 21 Strains and plasmids 22 All strains and plasmids used in this study are listed Table S1 . 23 For cultivation of bacteria, we used lysogeny broth (LB) containing appropriate antibiotics 24
(i.e., 50 µg/ml streptomycin (AppliChem); 6 µg/ml chloramphenicol (AppliChem); 50 µg/ml 25 kanamycin (AppliChem); 100 µg/ml ampicillin (AppliChem)). Dilutions were prepared in 26
Phosphate Buffer Saline (PBS, Difco) 27
In-frame deletion mutants (e.g. gtrC::cat) were performed by λ red recombination as 28 described in (42) . When needed, antibiotic resistance cassettes were removed using the 29 temperature-inducible FLP recombinase encoded on pCP20 (42) . Mutations coupled with 30
antibiotic resistance cassettes were transferred into the relevant genetic background by 31
generalized transduction with bacteriophage P22 HT105/1 int-201 (43) . Primers used for 32
genetic manipulations and verifications of the constructions are listed The gtrABC operon (STM0557-0559) was cloned into the pSC101 derivative plasmid 38
pM965 (44). The operon gtrABC was amplified from the chromosome of SB300 using the 39
Phusion Polymerase (ThermoFisher Scientific) and primers listed Table S2 . The PCR product 40
and pM965 were digested with PstI-HF and EcoRV-HF (NEB) before kit purification (SV 41
Gel and PCR Clean up System, Promega) and ligation in presence of T4 ligase (NEB) 42
following manufacturer recommendations. The ligation product was transferred by electro-43 transformation in competent SB300 cells. 44 45 Targeted sequencing 46 47 purified PCR products (Promega) from chromosomal DNA or expression vector templates 48
using pre-mixed sequencing primers listed Table S2 . 49 50 Whole-genome re-sequencing of O:12 Bimodal isolates 51
The genomes of S.Tm and evolved derivatives were fully sequenced by the Miseq system 52 (2x300bp reads, Illumina, San Diego, CA) operated at the Functional Genomic Center in 53
Zurich. The sequence of S.Tm SL1344 (NC_016810.1) was used as reference. Quality check, 54
reads trimming, alignments, SNPs and indels calling were performed using the bioinformatics 55
software CLC Workbench (Qiagen). 56 57
Whole-genome sequencing of S.Tm isolates from "Evolutionary trap" vaccinated mice 58
and variant calling. 59 Nextera XT libraries were prepared for each of the samples. The barcoded libraries were 60
pooled into equimolar concentrations following manufacturer's guidelines (Illumina, San 61
Diego, CA) using the Mid-Output Kit for paired-end sequencing (2×150 bp) on an Illumina 62
NextSeq500 sequencing platform. Raw data (mean virtual coverage 361x) was demultiplexed 63
and subsequently clipped of adapters using Trimmomatic v0.38 with default parameters (45) .
64
Quality control passing read-pairs were aligned against reference genome/plasmids 65 (Accession numbers: NC_016810.1, NC_017718.1, NC_017719.1, NC_017720.1) with bwa 66 v0.7.17 (46) . Genomic variant were called using Pilon v1.23 (47) . with the following 67 parameters: (i) minimum coverage 10x; (ii) minimum quality score = 20; (iii) minimum read 68
mapping quality = 10. SnpEff v4.3 was used to annotate variants according to NCBI and 69
predict their effect on genes (48) . 70 71
PA-S.Tm vaccinations 72
Peracetic acid killed vaccines were produced as previously described (49) . Briefly, bacteria 73
were grown overnight to late stationary phase, harvested by centrifugation and re-suspended 74
to a density of 10 9 -10 10 per ml in sterile PBS. Peracetic acid (Sigma-Aldrich) was added to a 75
final concentration of 0.4% v/v. The suspension was mixed thoroughly and incubated for 60 76 min at room temperature. Bacteria were washed once in 40 ml of sterile 10x PBS and 77 subsequently three times in 50 ml sterile 1x PBS. The final pellet was re-suspended to yield a 78 density of 10 11 particles per ml in sterile PBS (determined by OD600) and stored at 4°C for 79 up to three weeks. As a quality control, each batch of vaccine was tested before use by 80
inoculating 100 µl of the killed vaccine (one vaccine dose) into 300 ml LB and incubating 81 over night at 37 °C with aeration. Vaccine lots were released for use only when a negative 82 enrichment culture had been confirmed. 83 84
Non-typhoidal Salmonella challenge infections 85
Infections were carried out as described (50 the donor mice were euthanized, organs were harvested, and fecal pellets were collected, 108
weighed and homogenized in 1 ml of PBS. The re-suspended feces (centrifuged for 10 109 seconds to discard large debris) were immediately used to gavage (as a 50 µl volume 110
containing the bacteria from on fecal pellet) recipient naïve mice (pretreated with 25 mg 111 streptomycin 24 hours before infection). Recipient mice were euthanized and organs were 112 collected on day 2 post transmission. In both donor and recipient mice, fecal pellets were 113 collected daily and selective plating was used to enumerate Salmonella and determine the 114 relative proportions (and consequently the competitive index) of both competing bacterial 115 strains. 116 117
Quantification of fecal Lipocalin2 118
Fecal pellets collected at the indicated time-points were homogenized in PBS by bead-beating 119 at 25 Hz, 1min. Large particles were sedimented by centrifugation at 300 g, 1min. The 120
resulting supernatant was then analysed in serial dilution using the mouse Lipocalin2 ELISA 121 duoset (R&D) according to the manufacturer's instructions. 122 123
Analysis of IgA-coating, and O:5/O:12 expression on S.Tm in cecal content 124
Fresh cecal content or feces was re-suspended in sterile PBS by bead-beating at 25 Hz, 1min 125
(previously demonstrated to disrupt IgA cross-linked clumps (9)). An aliquot estimated to 126 contain not more than 10 6 S.Tm was directly stained with a monoclonal human IgG-anti-O:12 127 (STA5(9)) and biotin-conjugated anti-mouse IgA clone RMA- Analysis of specific antibody titers by bacterial flow cytometry 140 Specific antibody titers in mouse intestinal washes were measured by flow cytometry as 141 described (9, 51) . Briefly, intestinal washes were collected by flushing the small intestine with 142 5ml PBS, centrifuged at 16000 g for 30 min and aliquots of the supernatants were stored at -143 20°C until analysis. Bacterial targets (antigen against which antibodies are to be titered) were 144 grown to late stationary phase or the required OD, then gently pelleted for 2 min at 3000 g. 145
The pellet was washed with sterile-filtered 1% BSA/PBS before re-suspending at a density of 146 approximately 10 7 bacteria per ml. After thawing, intestinal washes were centrifuged again at 147 16000 g for 10 min. Supernatants were used to perform serial dilutions. 25 sequence with rotor synchronous refocusing pulses every two rotor periods before acquisition 200 of the last echo signal to remove broad lines due to solid-like material (27) . The 90° pulse was 201 set to 6.5 µs, the acquisition time was 1.36 s, the spectral width to 20 ppm. The signal of 202
HDO was attenuated using water presaturation for 2 s. 400 scans were recorded in a total 203
experimental time of about 30 minutes.
205 O-Antigen purification and 1 H-NMR 206
The LPS was isolated applying the hot phenol-water method(54), followed by dialysis against 207 distilled water until the phenol scent was gone. Atomic force microscopy 220
The indicated S.Tm strains were grown to late-log phase, pelleted, washed once with distilled 221 water to remove salt. A 20 µl of bacterial solution was deposited onto freshly cleaved mica, 222
adsorbed for 1 min and dried under a clean airstream. The surface of bacteria was probed 223 using a Dimension FastScan Bio microscope (Bruker) with Bruker AFM cantilevers in 224
tapping mode under ambient conditions. The microscope was covered with an acoustic hood 225
to minimized vibrational noise. AFM images were analyzed using the Nanoscope Analysis 226 1.5 software.
228
Methylation analysis of S.Tm clones 229
For REC-Seq (restriction enzyme cleavage-sequencing) we followed the same procedure 230 described by Ardissone et al, 2016 (56) . In brief, 1 µg of genomic DNA from each S.Tm was 231 cleaved with MboI, a blocked (5'biotinylated) specific adaptor was ligated to the ends and the 232 ligated fragments were then sheared to an average size of 150-400 bp (Fasteris SA, Geneva, 233 CH). Illumina adaptors were then ligated to the sheared ends followed by deep-sequencing 234 using a HiSeq Illumina sequencer, the 50 bp single end reads were quality controlled with 235 FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). To remove 236
contaminating sequences, the reads were split according to the MboI consensus motif (5'-237 ^GATC-3') considered as a barcode sequence using fastx_toolkit 238
(http://hannonlab.cshl.edu/fastx_toolkit/) (fastx_barcode_splitter.pl --bcfile barcodelist.txt --239
bol --exact). A large part of the reads (60%) were rejected and 40% kept for remapping to the 240 reference genomes with bwa mem (46) and samtools (57) to generate a sorted bam file. The 241
bam file was further filtered to remove low mapping quality reads (keeping AS >= 45) and 242 split by orientation (alignmentFlag 0 or 16) with bamtools (58) . The reads were counted at 5' 243 positions using Bedtools(59) (bedtools genomecov -d -5). Both orientation count files were 244 combined into a bed file at each identified 5'-GATC-3' motif using a home-made PERL 245
script. The MboI positions in the bed file were associated with the closest gene using 246
Bedtools closest (59) In vitro growth and competitions to determine wzyB-associated fitness costs Modeling antigen switching between O12 and O12-2 285 286
The aim of this modeling approach is to test whether a constant switching rate between an 287
O12 and an O12-2 antigen expression state can explain the experimentally observed bimodal 288
populations. 289 290
To this end, we formulated a deterministic model of population dynamics of the two 291 phenotypic states as 292 293
where !" and !"!! denote the population sizes of the respective antigen variants, denotes 296 the growth rate, which is assumed to be identical for the two variants, the carrying capacity, 297
and →!"!! and →!" the respective switching rates from !" to !"!! and from !"!! to 298 !" .Growth, as well as the antigen switching rates, are scaled with population size in a 299 logistic way, so that all processes come to a halt when carrying capacity is reached.
301
We use the model to predict the composition of a population after growth in LB overnight, 302
and therefore set the specific growth rate to = 2.05ℎ !! , which corresponds to a doubling 303 time of roughly 20min. The carrying capacity is set to = 10 ! . We ran parameter scans 304 for the switching rates →!" and →!"!! , with population compositions that start either with 305 100% or 0% !" , and measure the composition of the population after 16h of growth ( Fig.  306  S4C) . The initial population size is set to 10 ! 307 308
Experimentally, we observe that when starting a culture with an !" colony, after overnight 309 growth the culture is composed of around 90% !" and 10% !"!! cells, whereas starting the 310 culture with !"!! cells yields around 50% !" and 50% !"!! cells after overnight growth 311 (Fig. S4B) . To explain this observation without a change in switching rates, we would need a 312
combination of values in →!" and →!"!! that yield the correct population composition for 313 both scenarios. In Fig. S4D , we plot the values of →!" and →!"!! that yield values of 10% 314 !"!! (starting with 0% !"!! , green dots) and 50% !"!! (starting with 100% !"!! , 315 orange dots). The point clusters intersect at →!" = 0.144ℎ !! and →!"!! = 0.037ℎ !! (as 316 determined by a local linear regression at the intersection point).
318
We then used the thus determined switching rates to produce a population growth curve in a 319
in a deterministic simulation, using the above equations for a cultures starting with 100% 320 !"!! , (Fig. S4E , Left-hand graph) and for a culture starting with 0% !"!! (Fig. S4E, right-321 hand graph). 322 323
These switching rates are consistent with published values (22) . Our results show that the 324 observed phenotype distributions can be explained without a change in the rate of switching 325 between the phenotypes. 326 Verification deletion cluster SaltsV1_0712 to SaltsV1_0723
Key to O-glycan repeat structures in this manuscript
In frame deletion gtrA(a)
Verification deletion gtrA(a)
Verification deletion gtrC(a)
In frame deletion wzyB
Verification deletion wzyB
Cloning gtrABC(a)
Sequencing PrpsM-gtrABC(a)
